11:22 AM EDT, 06/13/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were sharply lower late Thursday morning, falling 1.60% to 1,418.28 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS ( EDAP ) and semiconductor company Sequans Communications ( SQNS ) , which increased 1.3% and 1% respectively. They were followed by biopharmaceutical companies argenx (ARGX) and Grifols ( GRFS ) , which were up 0.7% and 0.4% respectively.

The decliners from continental Europe were led by financial services company Banco Santander (SAN) and biopharmaceutical company Cellectis ( CLLS ) , which fell 5.2% and 4.3% respectively. They were followed by financial services company ING (ING), which dropped 3.9%.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Verona Pharma ( VRNA ) , which climbed 13% each. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) , which rose 8.1%.

The decliners from the UK and Ireland were led by communications company WPP ( WPP ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which lost 3.1% and 2% respectively. They were followed by cruise line operator Carnival (CUK) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which were down 1.8% each.